Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Perineal versus intravaginal electrical stimulation for idiopathic overactive bladder in women

Official title: Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder

Run by Pamukkale University · NCT07366918 · Data updated 2026-11-12

This study will test whether adding intravaginal or perineal electrical stimulation to bladder training helps women with idiopathic overactive bladder reduce urgency and leakage compared with bladder training alone.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment63 (estimated)
SponsorPamukkale University
Academic / other
Locations1 site (Denizli)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedJuly 29, 2026
Trial IDNCT07366918 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with idiopathic overactive bladder who are intolerant of or unresponsive to antimuscarinic or mirabegron therapy (off these drugs for at least 4 weeks) and who have pelvic floor muscle strength of at least 3/5 are ideal candidates.

Probably not a fit

Patients with pure stress urinary incontinence, recent conservative therapy for OAB, pregnancy, active vaginal or urinary infection, cancer, recent urogynecologic surgery, genital conditions preventing use of vaginal probes or perineal electrodes, or very weak pelvic floor muscles are unlikely to benefit or are ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, double-blind, placebo-controlled comparison enrolling 63 women with idiopathic overactive bladder who are intolerant of or unresponsive to oral OAB medications. Participants are randomized into three groups (intravaginal electrical stimulation plus bladder training, perineal electrical stimulation plus bladder training, or bladder training alone) and treated over an 8-week period. Clinical measures related to incontinence and quality of life are recorded before and after the treatment period. The study aims to determine whether one stimulation approach provides superior symptom relief and life-quality benefit compared with bladder training alone.

Why it matters

Potential benefit: If successful, the approach could offer a non-drug option that reduces urgency and leakage and improves quality of life for women with idiopathic OAB.

How similar studies have gone: Previous randomized trials and meta-analyses of pelvic electrical stimulation (including intravaginal and perineal approaches) have shown symptom improvement for some women with OAB, though results are mixed and effect sizes vary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women over the age of 18 with a clinical diagnosis of idiopathic OAB
* Intolerant or unresponsive to antimuscarinic or oral β3 adrenoceptor agonist (mirabegron) medications and not using them for at least 4 weeks
* Ability to understand the procedures, advantages, and potential side effects
* Ability to provide written, informed consent
* Pelvic floor muscle (PFM) strength of 3/5 or higher (modified Oxford scale, minimum: 0 - maximum: 5)

Exclusion Criteria:

* Women with pure stress urinary incontinence
* History of conservative treatment for OAB within the last 6 months (MI, IVES, perineal ES, etc.)
* Pregnant or planning to become pregnant at the time of the study
* Diagnosis of vaginal infection, urinary tract infection, or cancer
* Women with urinary incontinence within the last 3 months Those who have undergone urogynecological surgery
* Those with genital area disorders that may preclude the use of a vaginal probe or perineal electrode
* Those diagnosed with stage 2 or higher according to the Pelvic Organ Prolapse Assessment (POP-Q)
* Those with a pacemaker or implanted defibrillator
* Those with neurogenic bladder or a history of neurological disease
* Those with a urine residual of more than 100 ml detected by ultrasound (using an ultrasound device)
* Those with allergies to condoms or lubricating gels used with a vaginal probe or perineometer

Where it's running

  • Pamukkale University
    Denizli, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.